|
US4420497A
(en)
*
|
1981-08-24 |
1983-12-13 |
Fairchild Camera And Instrument Corporation |
Method of detecting and repairing latent defects in a semiconductor dielectric layer
|
|
US4510674A
(en)
*
|
1982-10-21 |
1985-04-16 |
Sovonics Solar Systems |
System for eliminating short circuit current paths in photovoltaic devices
|
|
CZ285118B6
(cs)
|
1991-03-05 |
1999-05-12 |
The Wellcome Foundation Limited |
Exprese rekombinačních proteinů v oslabených bakteriích
|
|
DE69233051T2
(de)
|
1991-10-25 |
2004-03-11 |
Immunex Corp., Seattle |
Antikörper gegen CD40-L
|
|
US7405270B2
(en)
|
1991-10-25 |
2008-07-29 |
Immunex Corporation |
CD40-Ligand lacking native-pattern glycosylation
|
|
US5981724A
(en)
|
1991-10-25 |
1999-11-09 |
Immunex Corporation |
DNA encoding CD40 ligand, a cytokine that binds CD40
|
|
US5962406A
(en)
|
1991-10-25 |
1999-10-05 |
Immunex Corporation |
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
|
|
CA2143299A1
(en)
|
1992-09-04 |
1994-03-17 |
University Of Saskatchewan |
Novel bacterial vaccines using vaccine strains of pathogenic bacteria
|
|
AU1059095A
(en)
|
1993-11-24 |
1995-06-13 |
Australian National University, The |
Treatment of viral disease with cd40l peptide
|
|
AU699291B2
(en)
|
1995-03-01 |
1998-11-26 |
Immunex Corporation |
Method for stimulating an immune response
|
|
AU693713B2
(en)
|
1995-06-07 |
1998-07-02 |
Immunex Corporation |
CD40L mutein
|
|
US5800632A
(en)
*
|
1995-09-28 |
1998-09-01 |
Canon Kabushiki Kaisha |
Photovoltaic device and method for manufacturing it
|
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
|
US6713279B1
(en)
|
1995-12-07 |
2004-03-30 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines and enzymes
|
|
US6306387B1
(en)
|
1997-05-29 |
2001-10-23 |
The Research Foundation Of State University Of New York |
Antigen delivery system
|
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
CA2223225A1
(en)
|
1997-11-28 |
1999-05-28 |
Canadian Red Cross Society |
Method for inhibiting in vivo immune response
|
|
JP2001526241A
(ja)
|
1997-12-19 |
2001-12-18 |
イミュネックス・コーポレーション |
Ｈｉｖ感染に対する感受性を低下させるための方法
|
|
GB9806449D0
(en)
|
1998-03-25 |
1998-05-27 |
Peptide Therapeutics Ltd |
Attenuated bacteria useful in vaccines
|
|
US6190669B1
(en)
|
1998-05-13 |
2001-02-20 |
University Of Maryland, Baltimore |
Attenuated mutants of salmonella which constitutively express the Vi antigen
|
|
US6248329B1
(en)
*
|
1998-06-01 |
2001-06-19 |
Ramaswamy Chandrashekar |
Parasitic helminth cuticlin nucleic acid molecules and uses thereof
|
|
PT1108034E
(pt)
|
1998-09-04 |
2008-11-14 |
Emergent Product Dev Uk Ltd |
Mutantes de spi2 de salmonela atenuados como transportadores de antigénios
|
|
US7300774B1
(en)
|
1999-12-09 |
2007-11-27 |
The Regents Of The University Of California |
Multimeric fusion proteins of the TNF superfamily ligands
|
|
EP1067194A1
(en)
|
1999-04-16 |
2001-01-10 |
F. Hoffmann-La Roche Ag |
Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof
|
|
JP2003508016A
(ja)
|
1999-04-16 |
2003-03-04 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｃｄ４０／ｃｄ４０ｌキメラポリペプチドをコードする核酸、それらの生成方法及びそれらの使用
|
|
US7118751B1
(en)
|
1999-10-14 |
2006-10-10 |
Trubion Pharmaceuticals, Inc. |
DNA vaccines encoding antigen linked to a domain that binds CD40
|
|
ES2222152T3
(es)
*
|
1999-12-28 |
2005-02-01 |
Akzo Nobel N.V. |
Vacuna con las salmonellas que no inducen anticuerpos que reaccionan con la flagelina o los flagelos.
|
|
CA2399790C
(en)
|
2000-02-02 |
2012-10-30 |
Ralph A. Tripp |
Cd40 ligand adjuvant for respiratory syncytial virus
|
|
MXPA02008748A
(es)
|
2000-03-17 |
2003-02-24 |
Upjohn Co |
Materiales y metodos para vacuna antisalmonella.
|
|
GB0015426D0
(en)
|
2000-06-24 |
2000-08-16 |
Univ Southampton |
Method for generating soluble highly multimeric proteins
|
|
WO2002036769A2
(en)
|
2000-10-31 |
2002-05-10 |
F. Hoffmann-La Roche Ag |
Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
|
|
US8703146B2
(en)
|
2001-04-20 |
2014-04-22 |
Institute For Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
EP2687593A1
(en)
|
2001-05-15 |
2014-01-22 |
Ortho-McNeil Pharmaceutical, Inc. |
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
|
|
US6923958B2
(en)
|
2002-03-02 |
2005-08-02 |
The Scripps Research Institute |
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
|
|
US8133493B2
(en)
*
|
2002-04-15 |
2012-03-13 |
Washington University |
Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
|
|
US7495090B2
(en)
|
2002-05-23 |
2009-02-24 |
The Regents Of The University Of California |
Nucleic acids encoding chimeric CD154 polypeptides
|
|
US20060014248A1
(en)
|
2003-01-06 |
2006-01-19 |
Xencor, Inc. |
TNF super family members with altered immunogenicity
|
|
US20050181994A1
(en)
|
2003-01-06 |
2005-08-18 |
Xencor, Inc. |
Novel variants of CD40L protein
|
|
US7754209B2
(en)
*
|
2003-07-26 |
2010-07-13 |
Trubion Pharmaceuticals |
Binding constructs and methods for use thereof
|
|
WO2005035570A2
(en)
|
2003-10-10 |
2005-04-21 |
Xencor, Inc. |
Variants of cd40l protein
|
|
CA2548347A1
(en)
|
2003-12-11 |
2005-06-30 |
Sidney Kimmel Cancer Center |
Methods for generating immunity to antigen
|
|
US8828957B2
(en)
|
2003-12-11 |
2014-09-09 |
Microvax, Llc |
Methods for generating immunity to antigen
|
|
US7098058B1
(en)
*
|
2004-01-15 |
2006-08-29 |
University Of Toledo |
Photovoltaic healing of non-uniformities in semiconductor devices
|
|
US20070128183A1
(en)
|
2004-04-27 |
2007-06-07 |
Intercell Ag |
Td antigens
|
|
WO2005113598A2
(en)
|
2004-05-21 |
2005-12-01 |
Xencor, Inc. |
Tnf super family members with altered immunogenicity
|
|
US20060249202A1
(en)
*
|
2004-09-20 |
2006-11-09 |
Seunghyup Yoo |
Photovoltaic cell
|
|
US8513008B2
(en)
|
2004-10-07 |
2013-08-20 |
Argos Therapeutics, Inc. |
Mature dendritic cell compositions and methods for culturing same
|
|
CN101080487B
(zh)
|
2004-10-07 |
2012-11-14 |
阿戈斯治疗公司 |
成熟树突细胞组合物及其培养方法
|
|
WO2006105972A1
(en)
|
2005-04-07 |
2006-10-12 |
Universite Libre De Bruxelles |
Transgenic organism expressing cd40l and uses thereof
|
|
US20060286074A1
(en)
|
2005-05-31 |
2006-12-21 |
Yucheng Tang |
Methods for immunotherapy of cancer
|
|
PL1949913T3
(pl)
|
2005-10-07 |
2010-10-29 |
Proyecto De Biomedicina Cima S L |
Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
|
|
CA2628837C
(en)
|
2005-11-07 |
2018-11-27 |
Sidney Kimmel Cancer Center |
Cd40 ligand fusion protein vaccine
|
|
WO2007054658A1
(en)
|
2005-11-14 |
2007-05-18 |
King's College London |
Control of immune responses
|
|
WO2007103048A2
(en)
|
2006-03-01 |
2007-09-13 |
Regents Of The University Of Colorado |
Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
|
|
US8802419B2
(en)
|
2006-03-02 |
2014-08-12 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
|
US20070227586A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Kla-Tencor Technologies Corporation |
Detection and ablation of localized shunting defects in photovoltaics
|
|
US8604178B2
(en)
*
|
2006-09-18 |
2013-12-10 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses
|
|
WO2008109825A2
(en)
|
2007-03-08 |
2008-09-12 |
Mayo Foundation For Medical Education And Research |
Inducing immune-mediated tumor cell death
|
|
PL3097926T3
(pl)
|
2007-11-01 |
2020-04-30 |
The Board Of Trustees Of The University Of Arkansas |
Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria
|